Enorama Pharma AB (publ) (STO:ERMA)

Enorama Pharma AB Revenue

In the year 2025, Enorama Pharma AB had annual revenue of 2.76M SEK, down -82.53%. Enorama Pharma AB had revenue of 1.76M in the quarter ending December 31, 2025, a decrease of -33.51%.

• Revenue: 2.76M
• Revenue Growth: -82.53%
• P/S Ratio: 13.81
• Revenue / Employee: 551.00K
• Employees: 5
• Market Cap: 38.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.76M	-13.01M	-82.53%
Dec 31, 2024	15.77M	14.41M	1,061.12%
Dec 31, 2023	1.36M	-5.49M	-80.17%
Dec 31, 2022	6.85M	-5.95M	-46.50%
Dec 31, 2021	12.80M	8.33M	186.40%